[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"neurofibromatosis-type-1-associated-plexiform-neurofibromas\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:neurofibromatosis-type-1-associated-plexiform-neurofibromas":20},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":4,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":4,"targetDuration":4,"studyType":17,"phases":4,"briefSummary":18,"conditions":19,"keywords":23,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":4,"completionDateStruct":4,"leadSponsor":34,"locationsCount":4},"100441423","individual-patient-compassionate-use-of-mirdametinib-100441423",false,"NCT05028166","Individual Patient Compassionate Use of Mirdametinib","Inclusion Criteria:\n\n* Patient has a serious, debilitating or life-threatening medical condition that cannot be treated satisfactorily with an authorized medicinal product or other available standard treatment options, or all other treatment options have been exhausted.\n* Patient does not qualify to participate in an ongoing clinical trial.","ALL","2 Years","EXPANDED_ACCESS","This program is being offered on a patient by patient basis and will require company, Institutional Review Board\u002FIndependent Ethics Committee, and applicable competent authority approval.",[20,21,22],"Neurofibromatosis Type 1-Associated Plexiform Neurofibromas","Histiocytic Neoplasm","Other MAP-K Pathway Driven Diseases",[24,25,26,27,28],"RASopathies","NF1","Neurofibromatosis","Plexiform Neurofibromas","Langerhans","AVAILABLE","2026-05-04",{"date":32,"type":33},"2026-05-08","ACTUAL",{"name":35,"class":36},"SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany","INDUSTRY"]